永福股份(300712.SZ):联合体中标2062万元的热电储能工程项目
格隆汇6月8日丨永福股份(300712.SZ)公布,公司于近日收到国网时代华电大同热电储能工程(全过程工程咨询服务项目)的《中标通知书》,公司与山东诚信工程建设监理有限公司)“山东诚信监理”)组成的联合体为该项目中标人,中标金额人民币2062万元(具体金额以届时签订的正式合同为准)。
项目规模:新建磷酸铁锂电池储能系统一套,建设规模为150MW/300MWh,预计占地25000平方米。
该项目中标金额2062万元,根据投标阶段联合体双方约定的合同工作量划分,公司所占金额约1649.6万元,约占公司2020年度经审计勘测设计业务营业收入27980.3415万元的5.90%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.